[ad_1]
According to the Ministry of Health, according to the BNS, under the preliminary agreement with two manufacturers AstraZeneca and Sanofi-GSK, Lithuania is expected to acquire approximately 3.7 million. vaccines – 1.86 million respectively. and 1,872 million. dose.
SAM emphasizes that it has not been fully decided whether the total quantity of vaccines will be purchased from Sanofi-GSK, and that the specific numbers will be decided by the government after consulting with specialists.
At that time, according to the agreement with the company Janssen Pharmaceutica NV, the amount of vaccines provided for Lithuania, which allows to vaccinate 1.24 million. population.
“For this company, it will be considered together with other EU countries if this amount can be reduced to the amount needed to vaccinate priority groups of the population,” SAM says.
According to her, clinical trials of all vaccines are currently underway, so the exact number of doses needed to vaccinate per person is unclear.
[ad_2]
